Larimar Therapeutics (LRMR) Short-term Investments (2014 - 2026)
Larimar Therapeutics (LRMR) posted Short-term Investments of $63.58 million for Q2 2026, down 46.1% from $117.94 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Short-term Investments (2014 - 2026) Analysis & Trends
At the end of FY2025, Larimar Therapeutics' Short-term Investments came in at $51.44 million, down 65.8% from FY2024.
- Annual Short-term Investments shows a five-year compound annual growth rate of 16.0% (FY2020 to FY2025).
- In prior years, Larimar Therapeutics' Short-term Investments was $150.24 million in FY2024 (+150.2%), $60.04 million in FY2023 (-34.5%) and $91.6 million in FY2022.
- Quarterly Short-term Investments has run from a low of $6.5 million in Q3 2021 to a high of $193.75 million in Q2 2024 over five years.
- On a year-over-year basis, Short-term Investments increased in three of the last seven quarters, with growth averaging 23.3%.
- The strongest year-over-year quarter for Short-term Investments in the past five years was Q3 2021, with growth of 549.3%; the weakest was Q2 2023, with a decline of 71.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Larimar Therapeutics | 279.45 Mn | -389.49 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.58 Mn |
| Mar 31, 2026 | 22.47 Mn |
| Dec 31, 2025 | 51.44 Mn |
| Sep 30, 2025 | 85.30 Mn |
| Jun 30, 2025 | 117.94 Mn |
| Mar 31, 2025 | 136.40 Mn |
| Dec 31, 2024 | 150.24 Mn |
| Sep 30, 2024 | 168.64 Mn |
| Jun 30, 2024 | 193.75 Mn |
| Mar 31, 2024 | 117.17 Mn |
| Dec 31, 2023 | 60.04 Mn |
| Sep 30, 2023 | 56.87 Mn |
| Jun 30, 2023 | 9.88 Mn |
| Dec 31, 2022 | 91.60 Mn |
| Sep 30, 2022 | 38.65 Mn |
| Jun 30, 2022 | 35.19 Mn |
| Sep 30, 2021 | 6.50 Mn |
| Mar 31, 2021 | 19.25 Mn |
| Dec 31, 2020 | 24.49 Mn |
| Sep 30, 2020 | 1.00 Mn |
API Access
Larimar Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();